Arnesen received funding from the Norwegian Cancer Society
Arnesen was one of eight researchers from Bergen who received funding
from the Norwegian Cancer Society.
Kreftforeningen.no 210 millioner til kreftforskning – gir nytt håp til fremtidens pasienter [Norwegian]
BA.no Benjamin har løpt, syklet, og gått for kreftforskning: – Har et hårete mål for 2025 [Norwegian]
Monica Hellesvik highlighted as a HoloMonitor user
Arnesen lab work highlighted by Essen Bioscience
Uncovering the Secrets of Cellular Motility: The Impact of Actin Nt-Acetylation on the Cytoskeleton
NAA80 Paper in featured publications for the IncuCyte Live-Cell Analysis System
Arnesen's tips for other ERC Consolidator Grant applicants
Forskningsradet.no Brukte ekspertevalueringene til å forbedre ERC-søknaden [Norwegian]
Copyright: European Union
The Arnesen Lab is part of a new European Proteomics Infrastructure Consortium
UiB.no: EPIC-XS: Ten Million Euro for Access to European Proteomics Facilities
Copyright: PNAS
The discovery of the actin's N-terminal acetyltransferase NAA80
Cytoskeleton commentary: Actin's N‐terminal acetyltransferase uncovered
PNAS commentary: NATure of actin amino-terminal acetylation
NBS Nytt: Actin Acetylation [Norwegian]
UiB.no: Putting a break on cell movement
Arnesen receives the ERC Consolidator Grant
UIB.no: ERC consolidator grant to Thomas Arnesen
Forskningsrådet.no: Banebrytende forskning ble belønnet [Norwegian]
Påhøyden.no: Får høythengende EU-midler [Norwegian]
Arnesen received funding from the Norwegian Cancer Society
NRK.no: Forsker fikk gave på 4,5 mill [Norwegian]
On the discovery of deadly gene defect in NAA10
Påhøyden.no: Deadly gene defect is uncovered
Thomas Arnesen and Johan Lillehaug
Arnesen receives the Bergen Research Foundation Starting Grant
Påhøyden.no: To nye rekrutteringsstipend [Norwegian]
Could NatA play a role in Huntington’s disease?
Påhøyden.no: Kreftforskere fant info om livsfarlig sykdom [Norwegian]
N-terminal acetyltransferases are conserved from yeast to human
Påhøyden.no Nye skritt mot bedre kreftmedisin [Norwegian]